You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

PREVACID IV Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Prevacid Iv patents expire, and when can generic versions of Prevacid Iv launch?

Prevacid Iv is a drug marketed by Takeda Pharms Na and is included in one NDA.

The generic ingredient in PREVACID IV is lansoprazole. There are fifty-six drug master file entries for this compound. Seventy suppliers are listed for this compound. Additional details are available on the lansoprazole profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Prevacid Iv

A generic version of PREVACID IV was approved as lansoprazole by MYLAN PHARMS INC on November 10th, 2009.

  Try a Trial

Drug patent expirations by year for PREVACID IV
Recent Clinical Trials for PREVACID IV

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Janssen Research & Development, LLCPhase 1
McGill University Health CenterPhase 4
McGill University Health Centre/Research Institute of the McGill University Health CentrePhase 4

See all PREVACID IV clinical trials

US Patents and Regulatory Information for PREVACID IV

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Takeda Pharms Na PREVACID IV lansoprazole INJECTABLE;INTRAVENOUS 021566-001 May 27, 2004 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for PREVACID IV

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Takeda Pharms Na PREVACID IV lansoprazole INJECTABLE;INTRAVENOUS 021566-001 May 27, 2004 ⤷  Try a Trial ⤷  Try a Trial
Takeda Pharms Na PREVACID IV lansoprazole INJECTABLE;INTRAVENOUS 021566-001 May 27, 2004 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for PREVACID IV

See the table below for patents covering PREVACID IV around the world.

Country Patent Number Title Estimated Expiration
Spain 546152 ⤷  Try a Trial
Hungary T39444 ⤷  Try a Trial
Latvia 5775 Piridina atvasinajumi un to iegusanas panemiens ⤷  Try a Trial
Canada 2419067 COMPOSITION INJECTABLE COMRENANT UN COMPOSE DE BENZIMIDAZOLEET UN ALKALI FORT (INJECTABLE COMPOSITION COMPRISING BENZIMIDAZOLE COMPOUND ANDSTRONG ALKALI) ⤷  Try a Trial
Denmark 171340 ⤷  Try a Trial
South Korea 920002128 ⤷  Try a Trial
Austria 42554 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for PREVACID IV

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0174726 SPC/GB94/011 United Kingdom ⤷  Try a Trial SPC/GB94/011, EXPIRES: 20051210
1129088 2014/008 Ireland ⤷  Try a Trial PRODUCT NAME: DEXLANSOPRAZOLE OR A SALT THEREOF; NAT REGISTRATION NO/DATE: PA1864/001/001-002;PA1864/002/001-002 20131125; FIRST REGISTRATION NO/DATE: 47911 47912 47913 47914 20130919
0174726 93C0021 Belgium ⤷  Try a Trial PRODUCT NAME: LANSOPRAZOLE; NAT. REG.: 150 S 539 F 4 19921119; FIRST REG.: FR 333 412.1 19901211
0328535 96C0021 Belgium ⤷  Try a Trial PRODUCT NAME: LANSOPRAZOLE + CLARITHROMYCINE + METRONIDAZOLE; REGISTRATION NO/DATE IN FRANCE: K 27 17033R DU 19960209; REGISTRATION NO/DATE AT EEC: K 27 17033R DU 19960209
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.